Literature DB >> 9064468

[Hepatic encephalopathy after portosystemic shunt].

D Jentschura1, L W Storz, B Rumstadt, M Winkler.   

Abstract

A total of 28 cirrhotic patients with porto-systemic anastomosis were compared with 38 cirrhotic patients without porto-systemic shunts concerning their mental state and biochemical parameters of importance for hepatic encephalopathy. A group of 37 metabolically healthy individuals provided the reference values for the psychometric test results and the EEG power spectra. Laboratory values for both groups showed marginal elevation of bilirubin, while the ammonia levels were significantly increased in the operated group. A significant difference was found concerning both the tyrosine level and that of the branched-chain amino acids. None of the patients who had surgical treatment showed clinical evidence of hepatic encephalopathy. Regarding the results in the flicker photometry, the non-shunted cirrhotic patients differed significantly from the healthy control subjects. For both the shunted and non-shunted cirrhotic patients, the results of the Viennese determination test and the number connection test indicated subclinical encephalopathy. We conclude that the elevated ammonia level in patients with porto-systemic anastomosis does not cause a significant mental disturbance. In well-selected patients, the porto-systemic end-side shunt is an appropriate procedure in the treatment of esophageal varices.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9064468     DOI: 10.1007/bf00184050

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  19 in total

1.  Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.

Authors:  J STAHL
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

2.  [On the pathophysiology and surgery of portal hypertension. A clinical and experimental contribution to the problem: portacaval side-to-side or end-to-end anastomosis?].

Authors:  H W SCHREIBER
Journal:  Langenbecks Arch Klin Chir Ver Dtsch Z Chir       Date:  1962

3.  Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

Authors:  A H Lockwood; E W Yap; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

4.  Plasma amino acids in dogs with two experimental forms of liver damage.

Authors:  A Aguirre; N Yoshimura; T Westman; J E Fischer
Journal:  J Surg Res       Date:  1974-04       Impact factor: 2.192

Review 5.  [Portal hypertension and percutaneous transjugular portasystemic stent shunt].

Authors:  G M Richter; T Roeren; M Brado; L Theilmann; P Sauer; G W Kauffmann
Journal:  Chirurg       Date:  1995-06       Impact factor: 0.955

6.  Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial.

Authors:  J T Galambos; W D Warren; D Rudman; R B Smith; A A Salam
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

7.  Loss of selectivity of Warren shunt in long-term observation.

Authors:  T Isomatsu
Journal:  Jpn J Surg       Date:  1983-05

8.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up.

Authors:  J P Cello; J H Grendell; R A Crass; T E Weber; D D Trunkey
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245

9.  [Liver transplantation in the treatment strategy of portal hypertension].

Authors:  H Bismuth; R Adam; J S Raccuia
Journal:  Chirurg       Date:  1995-06       Impact factor: 0.955

10.  Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication.

Authors:  M Hayashi; H Ohnishi; Y Kawade; Y Muto; Y Takahashi
Journal:  Gastroenterol Jpn       Date:  1981
View more
  1 in total

Review 1.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.